Global Fertility Services Market Is Projected To Grow At A CAGR Of 7.2% During The Forecast Period.

The global fertility services market was worth around $26,362 million in 2021 and is predicted to grow to around $36,256 million by 2028 at a CAGR rate of 7% over the forecast period. Fertility services are services that are offered to help with infertility treatment. These services include in vitro fertilization (IVF), surrogacy, artificial insemination, and other treatments that assist couples, single moms, and the LGBT community in overcoming infertility concerns. Men and women of childbearing age can both experience infertility. Furthermore, reduced sperm count or reduced sperm motility, which may be attributed to hormonal imbalance, are the most common causes of male infertility. As a result, the hypothalamus and pituitary gland must both work properly for men and women to be fertile. Increasing usage of alcohol & drugs, increased stress levels, obesity, frequent smoking, and environmental variables have all contributed to an increase in the likelihood of infertility.

The global fertility services market’s progress is likely to be driven by technological improvements in assisted reproductive technologies, increased knowledge about infertility treatment, and an increase in the number of fertility clinics throughout the forecast period. Additionally, as the number of reproductive clinics grows, so does public knowledge of fertility treatments such as sperm/egg donation and in-vitro fertilization elevates, resulting in increased acceptance of fertility treatments and hence market expansion. Furthermore, the rise in infertility rates is attributable to a variety of disorders, including sexually transmitted diseases (STDs) and fertility-related diseases, as well as lifestyle changes. As a result, the market for fertility treatments is expected to develop in the near future as infertility rates rise. However, the expensive costs of the procedures, as well as rigorous surrogacy legislation in certain countries, are limiting the market's growth.

The advancement of the global fertility services market was hampered during the COVID-19 pandemic. This is mainly attributed to the extreme burden on clinics, hospitals, and specialty healthcare centers to address the Covid patients, restrictions on public movements, and reduced clinic visits.

The global fertility services market in this research analysis is divided into infertility, procedure, services, end-user, and region. Infertility is classified as male infertility and female infertility. Procedures are segmented into assistive reproductive technology, In-Vitro fertilization, artificial insemination, surrogacy, and others. The services are donors and non-donors. End-users are hospitals, fertility clinics, clinical research institutes, and surgical centers.

Europe is currently the biggest region in the global fertility services market in terms of value. This is primarily attributed to the increasing number of obesities in European countries. Because of the breakthroughs made in the fertility services in the region, over 5.5 million individuals in Europe get fertility treatments in Denmark. Furthermore, Mexico has no legislative restrictions on IVF or egg donation, making it a popular location for infertility treatment. Iran also has the most up-to-date IVF technology for fertility treatments. As a result, despite market challenges, the fertility services business is predicted to develop steadily. On the other side, with the rising acceptance of IVF procedures in the area, the United States accounts for a significant chunk of the global market value.

The key players in the global fertility services market are Merck KGaA, Cook Medical, Irvine Scientific Company, Copper Surgical, Kitazato Cooperation, Vitrolife, Ferring B.V., Monash IVF Group, Care Fertility, Apollo Hospitals Enterprise Ltd, Carolinas Fertility Institute, Genea Limited, Medicover Group, Monash IVF Group Limited, Progyny Inc., and Virtus Health.

Recent developments:

• In 2021, Hamilton Thorne Ltd., a renowned producer of precision equipment, received FDA clearance for the commercialization of GYNEMED GM501, a novel ready-to-use medium for washing human embryos and oocytes for in vitro fertilization (IVF) treatments in Europe and the United States.

Browse the full “Fertility Services Market By Infertility (Male Infertility, Female Infertility), By Procedure (Assisted Reproductive Technology, In-Vitro Fertilization, Artificial Insemination, Surrogacy, Others), By Services (Donor, Non-Donor), By End-User (Hospitals, Fertility Clinics, Clinical Research Institutes, Surgical Centers), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2022 – 2028.” Report at https://www.zionmarketresearch.com/report/fertility-services-market

Global Fertility Services Market is segmented as follows:

By Infertility

• Male Infertility
• Female Infertility

By Procedure

• Assisted Reproductive Technology
• In-Vitro Fertilization
• Artificial Insemination
• Surrogacy
• Others

By Services

• Donor
• Non-Donor

By End-Users

• Hospitals
• Fertility Clinics
• Clinical Research Institutes
• Surgical Centres

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa

About Us:

Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com